# A Study of LY3841136 in Healthy and Overweight Participants

> **NCT05295940** · PHASE1 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 148 (actual)

## Conditions studied

- Obesity
- Healthy

## Interventions

- **DRUG:** LY3841136
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05295940
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-30
- **Primary completion:** 2024-01-25
- **Final completion:** 2024-01-25
- **Target enrollment:** 148 (ACTUAL)
- **Last updated:** 2024-04-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05295940

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05295940, "A Study of LY3841136 in Healthy and Overweight Participants". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05295940. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*